1.
Esquenazi A, Bloudek L, Migliaccio-Walle K, Oliveri D, Tung A, Gillard P, Verduzco-Gutierrez M. Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina. JRM [Internet]. 2023 Oct. 30 [cited 2024 Jul. 9];55:jrm11626. Available from: https://medicaljournalssweden.se/jrm/article/view/11626